Skip to main content

Table 3 Summary of five patients treated with more than ten 3 g doses of oral fosfomycin for UTI

From: Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study

Study number

Age group at first dose (years)

Gender

Clinical background, including possible risk factors for UTI

Urine culture result

Total number of 3 g fosfomycin doses

eGFR at baseline

Any reported side-effects

Notes on outcome

FOS015

80–89

M

Vasculopath; bilateral below knee amputations. Recurrent E. coli bacteraemia with unclear source despite extensive investigation. Relapsed after a treatment course of iv ertapenem

ESBL E. coli

36

79

None reported

Well when reviewed following end of treatment course; discharged from clinic

FOS038

60–69

M

History of recurrent UTI for > 10 years. Dilatation for urethral stricture, followed by TURP. Prostate cancer confirmed; treated post-op with radiotherapy

ESBL E. coli

81

>90

None reported

Interval free of infection, followed by recurrence of UTI (different organisms)

FOS060

60–69

M

Relapsing urosepsis following TRUS biopsy (negative for prostate cancer). Presumed prostatitis as focus of infection.

ESBL E. coli

33

79

Reported shortness of breath during treatment, but thought unlikely to be related to fosfomycin

Well when reviewed following end of treatment course; discharged from clinic

FOS098

70–79

M

Transitional cell carcinoma treated with nephrouretectomy. Regular surveillance cystoscopy complicated by recurrent UTI; recurred after completing treatment with meropenem.

ESBL E. coli

49

41

None reported

Interval free of infection, followed by recurrence and re-treatment with fosfomycin

FOS140

40–49

F

Recurrent UTI following sling procedure and botox treatment for stress/urge incontinence. Intermittent self-catheterisation. Good symptomatic relief with fosfomycin.

E. coli

15

>90

None reported

Ongoing prophylaxis while awaiting urogynaecology surgery

  1. eGFR estimated glomerular filtration rate, TURP trans-urethral resection of the prostate, TRUS trans-rectal ultrasound guided prostate biopsy